Show
Sort by
-
Scientific Business Abstracts
-
Global access and patient safety in the transition to environmentally friendly respiratory inhalers : the Global Initiative for Asthma perspective
-
- Journal Article
- A1
- open access
Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes
-
Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes
-
- Journal Article
- A1
- open access
Global initiative for Asthma Strategy 2021 : executive summary and rationale for key changes
-
- Journal Article
- A1
- open access
Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes
-
- Journal Article
- A1
- open access
Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes
-
- Journal Article
- A1
- open access
ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)
-
- Journal Article
- A1
- open access
Management of anaphylaxis due to COVID‐19 vaccines in the elderly
-
- Journal Article
- A1
- open access
ARIA‐EAACI care pathways for allergen immunotherapy in respiratory allergy
-
ARIA digital anamorphosis : digital transformation of health and care in airway diseases from research to practice
-
Cabbage and fermented vegetables : from death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19
-
Next-generation Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence
-
- Journal Article
- A1
- open access
Nrf2-interacting nutrients and COVID-19 : time for research to develop adaptation strategies
-
From ARIA guidelines to the digital transformation of health in rhinitis and asthma multimorbidity